Application of Megavoltage Imaging to Reduce Artifact After Seed Implants
Status: | Completed |
---|---|
Conditions: | Prostate Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 50 - 80 |
Updated: | 9/28/2017 |
Start Date: | September 2013 |
End Date: | April 2016 |
Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma
This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure
in patients treated with interstitial permanent seed implants for low and intermediate risk
prostate cancer. All patients will received the same standard of care treatment but will
receive an additinoal CT image of the prostate.
in patients treated with interstitial permanent seed implants for low and intermediate risk
prostate cancer. All patients will received the same standard of care treatment but will
receive an additinoal CT image of the prostate.
Inclusion Criteria:
Male 50-80 years of age Eligible for interstitial brachytherapy implants
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials